HEALTH IN TECH ($HIT) posted quarterly earnings results for Q4 2025 on Wednesday, March 25th. The company reported earnings of -$0.01 per share, beating estimates of -$0.01 by $0.00. The company also reported revenue of $7,510,000, beating estimates of $7,346,235 by $163,765.
Stock price change since market close: -16.72%
You can see Quiver Quantitative's $HIT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HEALTH IN TECH Hedge Fund Activity
We have seen 15 institutional investors add shares of HEALTH IN TECH stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 294,440 shares (+268.4%) to their portfolio in Q4 2025, for an estimated $468,159
- VANGUARD GROUP INC added 284,105 shares (+79.8%) to their portfolio in Q4 2025, for an estimated $451,726
- BLACKROCK, INC. added 152,029 shares (+114.6%) to their portfolio in Q4 2025, for an estimated $241,726
- RENAISSANCE TECHNOLOGIES LLC added 134,317 shares (+inf%) to their portfolio in Q4 2025, for an estimated $213,564
- XTX TOPCO LTD added 127,495 shares (+inf%) to their portfolio in Q4 2025, for an estimated $202,717
- CUBIST SYSTEMATIC STRATEGIES, LLC removed 58,595 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $188,089
- GEODE CAPITAL MANAGEMENT, LLC added 54,217 shares (+46.6%) to their portfolio in Q4 2025, for an estimated $86,205
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
